B2RLaw has advised the Life Science Innovation Fund on an unspecified investment in telemedicine startup Aidlab.
Life Science Innovation Fund is a Polish venture capital fund that invests in MedTech, BioTech, and Health Care. According to B2RLaw, “the aim of the investment is to develop a new product, Aidmed, a device which remotely diagnoses diseases, particularly sleep breathing and cardiac disorders.”
B2RLaw’s team consisted of Partner Szymon Syp and Senior Associate Iga Wojtczak-Opala.
